Retatrutide
Research Peptide
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist studied in metabolic and energy-balance research models.
Product Overview
Retatrutide is a triple agonist peptide engineered to act at the GIP, GLP-1, and glucagon receptors. It is a reference compound in metabolic-research models studying energy expenditure, glucose handling, and lipid metabolism.
Evercore Labs LLC supplies Retatrutide from 5mg up to 60mg per vial across 8 sizes, synthesized to analytical purity and independently third-party tested, with a lot-matched Certificate of Analysis available before purchase — including a published 20mg batch (99.97% purity, Freedom Diagnostics).
Research Applications
- Studied as a triple GIP/GLP-1/glucagon receptor agonist
- Investigated in energy-expenditure and glucose-handling research
- Used in lipid-metabolism research models
- Compared against single- and dual-agonist reference compounds
Compound Specifications
| Purity | ≥99% (HPLC-UV Verified, 99.97% typical) |
|---|---|
| Appearance | White lyophilized powder |
| Format | Lyophilized powder, vial |
Storage & Handling
Store lyophilized material at -20°C, protected from light and moisture. Once reconstituted, refrigerate at 2–8°C and use within the timeframe noted on the product COA.
COA & Downloads
Lot-matched Certificates of Analysis for this compound. Each batch is independently tested before release.
Related products
-
Read MoreTirzepatide
Price range: $295.00 through $2,090.00 -
Read MoreCagrilintide
Price range: $735.00 through $1,770.00 -
Read MoreSemaglutide
Price range: $195.00 through $505.00